According to a report by the American Thoracic Society, the occurrence of sleep disorders that have not been diagnosed among people having significant levels of insomnia and sleep apnea were 93.3% and 97.6%, respectively. It shows a high prevalence of undiagnosed sleep disorders among the African-American population, and this needs to be treated across population groups. Actigraphy sensors and PSG devices are useful tools that are used to monitor sleep patterns and for the diagnosis of various sleep disorders such as obstructive sleep apnea, central sleep apnea, and idiopathic hypersomnia.
According to a recent study by Fact.MR, the global actigraphy sensors and PSG devices market is expected to reach around US$ 2,500 Mn in terms of value by 2026 end. The detailed report about the actigraphy sensors and PSG devices market further projects significant growth in the market at a CAGR of 4.6% through to 2026.
Increased stress levels and the rising prevalence of sleeping disorders, including sleep apnea, insomnia, narcolepsy, narcolepsy, and restless leg syndrome are expected to create growth opportunities for the actigraphy sensors and PSG devices market. Moreover, various government authorities and sleep associations, for example, the American Sleep Apnea Association (ASAA), are continuously working on increasing the awareness among the population about the importance of sleep, and the role of actigraphy sensors and PSG devices in managing sleep disorder. This would positively impact the demand for actigraphy sensors and PSG devices.
The rising geriatric population is an important factor that can increase the growth of the actigraphy sensors and PSG devices market. According to the Census Bureau report in 2016, funded by NIH, more than 8% of the global population is aged 65 and above, and this is expected to grow to around 17% by 2050. The frequent occurrence of lifestyle-related diseases and rising geriatric population are expected to fuel the growth of the actigraphy sensors and PSG devices market.
Technological advancements in actigraphy sensors and PSG devices have led to the introducing of hybrid devices that track activity and also track sleeping patterns. These actigraphy sensors and PSG devices are capable of tracking fitness aspects, and can also track sleep patterns like REM and deep & light sleep. Tracking activity/fitness and sleep patterns make these devices more versatile and efficient. Thus, the introduction of hybrid devices and consistent technological advancements have increased the adoption of actigraphy sensors and PSG devices.
The actigraphy sensors and PSG devices market has been segmented based on product type, distribution channel, technology, and region. By product type, the actigraphy sensors and PSG devices market is segmented into actigraphy devices and polysomnography devices. Actigraphy devices are further sub-segmented into wrist and handband actigraphy devices and wearable actigraphy devices. Polysomnography devices are further sub-segmented into fixed polysomnography devices and portable polysomnography devices.
By distribution channel, the actigraphy sensors and PSG devices market is segmented into retail stores, online retail stores, pharmacies, hospitals, and diagnostic laboratories. Among these, the online retail stores segment is a prominent segment in the distribution channels in the actigraphy sensors and PSG devices market.
By technology, actigraphy sensors and PSG devices market has been segmented into actigraphy sensors and PSG devices with wireless technology, actigraphy sensors and PSG devices with USB technology, actigraphy sensors and PSG devices with GPS technology, and actigraphy sensors and PSG devices with other technologies.
Europe and North America are expected to be key markets, due to an increase in the per capita healthcare expenditure and favorable reimbursement coverage. The Asia Pacific actigraphy sensors and PSG devices market is expected to experience a significant growth rate, due to the favorable healthcare landscape.
Fact.MR’s report tracks some of the key companies operating in the actigraphy sensors and PSG devices market, such as Koninklijke Philips N.V., Fitbit, Inc., Garmin Ltd., ResMed Inc., BMC Medical Co., Ltd., Activinsights Ltd., SOMNOmedics GmbH, MEDISANA GmbH, Recorders & Medicare Systems Pvt Ltd, Compumedics, Ltd, Natus Medical, Inc, Cleveland Medical Devices Inc., Cidelec, iHealth Labs Inc., Medicom MTD, ActiGraph, LLC, and Nox Medical.